《沪深股市》上证深成微微高开 国寿续升高开3%
国务院总理李克强主持召开国务院常务会议,部署深入做好新增财政资金直接惠企利民工作,巩固经济恢复性增长基础。人行开展500亿元人民币(下同)7天期逆回购操作,净投放500亿元。人汇靠稳向上,上证深成微微高开。
上证高开3点,报3,441点;深成高开6点,报13,748点;沪深300指数高开1点,报4,816;创业板指数高开6点或0.2%,报2,702点。
国寿(601628.SH)高开3%。券商股偏淡,中信建投(601066.SH)低开1%,中信证券(600030.SH)靠稳。
特斯拉概念股持续上扬,华昌达(300278.SZ)、京威股份(002662.SZ)分别高开5.1%及4.8%。(ta/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.